Opportunity ID: 297727

General Information

Document Type: Grants Notice
Funding Opportunity Number: PA-17-495
Funding Opportunity Title: Multilevel Interventions in Cancer Care Delivery: Follow-up to Abnormal Screening Tests (R01 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.394 — Cancer Detection and Diagnosis Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Sep 29, 2017
Last Updated Date:
Original Closing Date for Applications: Jan 07, 2021
Current Closing Date for Applications: Jan 07, 2021
Archive Date: Feb 12, 2021
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
County governments
Native American tribal organizations (other than Federally recognized tribal governments)
Special district governments
Public housing authorities/Indian housing authorities
Small businesses
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
State governments
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Independent school districts
Private institutions of higher education
For profit organizations other than small businesses
City or township governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: This Funding Opportunity Announcement (FOA) encourages applications that develop and test multilevel interventions to improve follow-up to abnormal screening tests for breast, cervical, colorectal, or lung cancers. Improving follow-up to abnormal screening tests is dependent on factors at the patient, provider, clinical team, clinic, healthcare institution, or community setting levels. Appropriate applications for this FOA should propose to intervene at two or more levels, and measure outcomes at three or more levels, while accounting for interactions that occur between and across levels.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PA-17-495.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-E Use for due dates on or before May 24, 2020 PKG00235408 Oct 27, 2017 May 24, 2020 View
FORMS-F Use for due dates on or after May 25, 2020 PKG00259034 Jan 05, 2018 Jan 07, 2021 View

Package 1

Mandatory forms

297727 RR_SF424_2_0-2.0.pdf

297727 PHS398_CoverPageSupplement_4_0-4.0.pdf

297727 RR_OtherProjectInfo_1_4-1.4.pdf

297727 PerformanceSite_2_0-2.0.pdf

297727 RR_KeyPersonExpanded_2_0-2.0.pdf

297727 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

297727 RR_Budget_1_4-1.4.pdf

297727 RR_SubawardBudget30_1_4-1.4.pdf

297727 PHS398_ModularBudget_1_2-1.2.pdf

297727 PHS_AssignmentRequestForm_2_0-2.0.pdf

Package 2

Mandatory forms

297727 RR_SF424_2_0-2.0.pdf

297727 PHS398_CoverPageSupplement_5_0-5.0.pdf

297727 RR_OtherProjectInfo_1_4-1.4.pdf

297727 PerformanceSite_2_0-2.0.pdf

297727 RR_KeyPersonExpanded_2_0-2.0.pdf

297727 PHS398_ResearchPlan_4_0-4.0.pdf

297727 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

297727 RR_Budget_1_4-1.4.pdf

297727 RR_SubawardBudget30_1_4-1.4.pdf

297727 PHS398_ModularBudget_1_2-1.2.pdf

297727 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-09T17:56:22-05:00

Share This Post, Choose Your Platform!

About the Author: